Palifermin use in patients , out of clinical investigation, which are receiving chemioterapic therapy with staminal cells to reduce severuty and incidence of mucositis. - ND

Phase 1

• Conditions: mucositis; MedDRA version: 9.1Level: LLTClassification code 10028128Term: Mucositis management

• Registration Number: EUCTR2006-001923-20-IT
• Lead Sponsor: OSPEDALE S. RAFFAELE

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-03-01
• Last Update Posted: 26 October 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

age 18 ;paz. with staminal cells trasplantation after mieloablative conditioning procedures; patients affected by non Hodking s linfoma,Hodcking disease, mieloid leucemia,leucemia mieloide acuta, linfoblastic acute leucemia , chronic linphatic leucemia or multiple mieloma
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

hospitalization and myocardial infarction 30 days before the start of the trial; inadeguate contraception;nursing.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified